667, L.P. - Insider Non-Derivative Transactions at Neoleukin Therapeutics, Inc. (NLTX) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Aug 17, 2023, 667, L.P.'s relationship to Neoleukin Therapeutics, Inc. (NLTX) is Director,TenPercentOwner, and currently has 5,612,949 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other NLTX insiders.

Data Source: SEC.
667, L.P. - Insider Non-Derivative Transactions of NLTX Common Stock
667, L.P. - Insider Non-Derivative Transactions at NLTX
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Aug 18, 2023 P -- (Common Stock) 7676 0.69 489092
Aug 18, 2023 P -- (Common Stock) 5041 0.69 494133
Aug 18, 2023 P -- (Common Stock) 93091 0.69 5551815
Aug 18, 2023 P -- (Common Stock) 61134 0.69 5612949
Aug 17, 2023 P -- (Common Stock) 17124 0.68 481050
Aug 17, 2023 P -- (Common Stock) 366 0.68 481416
Aug 17, 2023 P -- (Common Stock) 207676 0.68 5454290
Aug 17, 2023 P -- (Common Stock) 4434 0.68 5458724
Aug 16, 2023 P -- (Common Stock) 143519 0.63 463568
Aug 16, 2023 P -- (Common Stock) 358 0.67 463926
Aug 16, 2023 P -- (Common Stock) 1740581 0.63 5242272
Aug 16, 2023 P -- (Common Stock) 4342 0.67 5246614